Anti - Proliferative and apoptotic activities of müllerian inhibiting substance combined with calcitriol in ovarian cancer cell lines

Yeon Soo Jung, Hee Jung Kim, Seok Kyo Seo, Young Sik Choi, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Hyuck Dong Han, Jae Wook Kim, YoungTae Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: This study aimed to investigate whether Müllerian inhibiting substance (MIS) in combination with calcitriol modulates proliferation and apoptosis of human ovarian cancer (OCa) cell lines (SKOV3, OVCAR3, and OVCA433) and identify the signaling pathway by which MIS mediates apoptosis. Materials and Methods: OCa cell lines were treated with MIS in the absence or presence of calcitriol. Cell viability and proliferation were evaluated using the Cell Counting Kit-8 assay and apoptosis was evaluated by DNA fragmentation assay. Western blot and enzyme-linked immunosorbent assay were used to determine the signaling pathway. Results: The cells showed specific staining for the MIS type II receptor. Treatment of OCa cells with MIS and calcitriol led to dose-and time-dependent inhibition of cell growth and survival. The combination treatment significantly suppressed cell growth, down-regulated the expression of B-cell lymphoma 2 (Bcl-2), and up-regulated the expressions of Bcl-2 associated X protein, caspase-3, and caspase-9 through the extracellular signal-regulated kinase signaling pathway. Conclusion: These results, coupled with a much-needed decrease in the toxic side effects of currently employed therapeutic agents, provide a strong rationale for testing the therapeutic potential of MIS, alone or in combination with calcitriol, in the treatment of OCa.

Original languageEnglish
Pages (from-to)33-40
Number of pages8
JournalYonsei medical journal
Volume57
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Calcitriol
Ovarian Neoplasms
Cell Line
B-Cell Lymphoma
Apoptosis
Cell Survival
Therapeutics
Caspase 9
Poisons
Extracellular Signal-Regulated MAP Kinases
DNA Fragmentation
Growth
Caspase 3
Western Blotting
Enzyme-Linked Immunosorbent Assay
Cell Proliferation
Staining and Labeling
Proteins

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Jung, Yeon Soo ; Kim, Hee Jung ; Seo, Seok Kyo ; Choi, Young Sik ; Nam, Eun Ji ; Kim, Sunghoon ; Kim, Sang Wun ; Han, Hyuck Dong ; Kim, Jae Wook ; Kim, YoungTae. / Anti - Proliferative and apoptotic activities of müllerian inhibiting substance combined with calcitriol in ovarian cancer cell lines. In: Yonsei medical journal. 2016 ; Vol. 57, No. 1. pp. 33-40.
@article{1d65979fbf0e4deba1e5be8b9d854da3,
title = "Anti - Proliferative and apoptotic activities of m{\"u}llerian inhibiting substance combined with calcitriol in ovarian cancer cell lines",
abstract = "Purpose: This study aimed to investigate whether M{\"u}llerian inhibiting substance (MIS) in combination with calcitriol modulates proliferation and apoptosis of human ovarian cancer (OCa) cell lines (SKOV3, OVCAR3, and OVCA433) and identify the signaling pathway by which MIS mediates apoptosis. Materials and Methods: OCa cell lines were treated with MIS in the absence or presence of calcitriol. Cell viability and proliferation were evaluated using the Cell Counting Kit-8 assay and apoptosis was evaluated by DNA fragmentation assay. Western blot and enzyme-linked immunosorbent assay were used to determine the signaling pathway. Results: The cells showed specific staining for the MIS type II receptor. Treatment of OCa cells with MIS and calcitriol led to dose-and time-dependent inhibition of cell growth and survival. The combination treatment significantly suppressed cell growth, down-regulated the expression of B-cell lymphoma 2 (Bcl-2), and up-regulated the expressions of Bcl-2 associated X protein, caspase-3, and caspase-9 through the extracellular signal-regulated kinase signaling pathway. Conclusion: These results, coupled with a much-needed decrease in the toxic side effects of currently employed therapeutic agents, provide a strong rationale for testing the therapeutic potential of MIS, alone or in combination with calcitriol, in the treatment of OCa.",
author = "Jung, {Yeon Soo} and Kim, {Hee Jung} and Seo, {Seok Kyo} and Choi, {Young Sik} and Nam, {Eun Ji} and Sunghoon Kim and Kim, {Sang Wun} and Han, {Hyuck Dong} and Kim, {Jae Wook} and YoungTae Kim",
year = "2016",
month = "1",
day = "1",
doi = "10.3349/ymj.2016.57.1.33",
language = "English",
volume = "57",
pages = "33--40",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "1",

}

Anti - Proliferative and apoptotic activities of müllerian inhibiting substance combined with calcitriol in ovarian cancer cell lines. / Jung, Yeon Soo; Kim, Hee Jung; Seo, Seok Kyo; Choi, Young Sik; Nam, Eun Ji; Kim, Sunghoon; Kim, Sang Wun; Han, Hyuck Dong; Kim, Jae Wook; Kim, YoungTae.

In: Yonsei medical journal, Vol. 57, No. 1, 01.01.2016, p. 33-40.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti - Proliferative and apoptotic activities of müllerian inhibiting substance combined with calcitriol in ovarian cancer cell lines

AU - Jung, Yeon Soo

AU - Kim, Hee Jung

AU - Seo, Seok Kyo

AU - Choi, Young Sik

AU - Nam, Eun Ji

AU - Kim, Sunghoon

AU - Kim, Sang Wun

AU - Han, Hyuck Dong

AU - Kim, Jae Wook

AU - Kim, YoungTae

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Purpose: This study aimed to investigate whether Müllerian inhibiting substance (MIS) in combination with calcitriol modulates proliferation and apoptosis of human ovarian cancer (OCa) cell lines (SKOV3, OVCAR3, and OVCA433) and identify the signaling pathway by which MIS mediates apoptosis. Materials and Methods: OCa cell lines were treated with MIS in the absence or presence of calcitriol. Cell viability and proliferation were evaluated using the Cell Counting Kit-8 assay and apoptosis was evaluated by DNA fragmentation assay. Western blot and enzyme-linked immunosorbent assay were used to determine the signaling pathway. Results: The cells showed specific staining for the MIS type II receptor. Treatment of OCa cells with MIS and calcitriol led to dose-and time-dependent inhibition of cell growth and survival. The combination treatment significantly suppressed cell growth, down-regulated the expression of B-cell lymphoma 2 (Bcl-2), and up-regulated the expressions of Bcl-2 associated X protein, caspase-3, and caspase-9 through the extracellular signal-regulated kinase signaling pathway. Conclusion: These results, coupled with a much-needed decrease in the toxic side effects of currently employed therapeutic agents, provide a strong rationale for testing the therapeutic potential of MIS, alone or in combination with calcitriol, in the treatment of OCa.

AB - Purpose: This study aimed to investigate whether Müllerian inhibiting substance (MIS) in combination with calcitriol modulates proliferation and apoptosis of human ovarian cancer (OCa) cell lines (SKOV3, OVCAR3, and OVCA433) and identify the signaling pathway by which MIS mediates apoptosis. Materials and Methods: OCa cell lines were treated with MIS in the absence or presence of calcitriol. Cell viability and proliferation were evaluated using the Cell Counting Kit-8 assay and apoptosis was evaluated by DNA fragmentation assay. Western blot and enzyme-linked immunosorbent assay were used to determine the signaling pathway. Results: The cells showed specific staining for the MIS type II receptor. Treatment of OCa cells with MIS and calcitriol led to dose-and time-dependent inhibition of cell growth and survival. The combination treatment significantly suppressed cell growth, down-regulated the expression of B-cell lymphoma 2 (Bcl-2), and up-regulated the expressions of Bcl-2 associated X protein, caspase-3, and caspase-9 through the extracellular signal-regulated kinase signaling pathway. Conclusion: These results, coupled with a much-needed decrease in the toxic side effects of currently employed therapeutic agents, provide a strong rationale for testing the therapeutic potential of MIS, alone or in combination with calcitriol, in the treatment of OCa.

UR - http://www.scopus.com/inward/record.url?scp=84949844524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949844524&partnerID=8YFLogxK

U2 - 10.3349/ymj.2016.57.1.33

DO - 10.3349/ymj.2016.57.1.33

M3 - Article

VL - 57

SP - 33

EP - 40

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 1

ER -